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Abstract 13 
 14 
 Microalgae can be used for many applications, including the development of 15 
third generation biofuels. However, the trade-off between biomass production and lipid 16 
accumulation and productivity still impairs the viable production of sustainable biofuel 17 
from microalgae because neutral lipids accumulate under stress conditions. Recently, 18 
in the model marine diatom Phaeodactylum tricornutum, it was shown that inhibiting the 19 
target of rapamycin (TOR) kinase using specific ATP-competitive inhibitors could 20 
overcome this issue. We believe that basic knowledge in this rather new field is 21 
required to develop innovative strategies to improve neutral lipid accumulation in 22 
oleaginous microalgae. In this minireview, we therefore focused on the current 23 
research on the TOR signaling pathway with a focus on its control of lipid homeostasis. 24 
Since TOR has been well-studied in animals, we first describe the effectors of TOR in 25 
animal lipogenesis, adipogenesis and lipolysis. We then propose a tentative model of 26 
TOR regulation of TAG accumulation in algae, a process that has hitherto been 27 
overlooked. 28 
 29 
 30 
1. Importance of lipids in 3rd generation biofuels from microalgae  31 
 32 
 Lipids, together with carbohydrates, proteins and nucleic acids are essential 33 
components of living cells. While glycerophospholipids, sphingolipids, glycolipids and 34 
sterol lipids are the main components of cell membranes and can also function as 35 
signal transducers, triacylglycerols (TAG) constitute a universal form of transient energy 36 
storage in the form of fatty acids esterified with glycerol. They are found for instance in 37 
the core of lipid droplets in mammalian adipose tissues, in plant seeds, oleaginous 38 
yeasts and microalgae. They are the most abundant neutral lipid species in oils of plant 39 
origin. Stored TAGs can fuel the cell in times of nutrient limitation. The pathway leading 40 
to neutral lipid synthesis is fairly well conserved among eukaryotes: acetyl-CoA derived 41 
from carbon-metabolism is the substrate for de novo fatty acid (FA) synthesis, FAs are 42 
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then conjugated to existing lipophilic alcohols through a series of acylation reactions in 43 
which diacylglycerol (DAG) is the last intermediate before TAG [1]. A particularity of 44 
plant and algae is that the chloroplast is the major site of de novo FA synthesis [2]. 45 
Cellular TAGs and other neutral storage lipids such as steryl esters are stored in lipid 46 
droplets, and their content can vary considerably depending on cell type and external 47 
environmental cues. For example, plants store TAGs in seeds in order to support the 48 
germination and vegetative growth of the next generation, while microalgae and yeast 49 
accumulate TAGs during starvation. 50 
 In the modern world the increasing energy demand from human activities 51 
threatens the availability of finite natural resources and the environment due to the 52 
release of CO2 and other pollutants. Against this background, neutral lipids represent a 53 
promising renewable resource for the biofuel industry, as well as for human and animal 54 
nutrition and health. Oleaginous microorganisms, including certain microalgae, yeasts 55 
and bacteria, can accumulate up to 80% of their biomass in the form of TAGs under 56 
appropriate conditions [3, 4]. These organisms therefore represent a major resource for 57 
the development of third generation biofuels. Algae are a polyphyletic group of 58 
photosynthetic organisms that evolved from multiple endosymbiotic events. The 59 
endosymbiosis of a cyanobacterium by a non-photosynthetic eukaryote led to the 60 
Archaeplastida group of chloroplast-containing eukaryotes which includes red algae, 61 
glaucophytes, green algae and land plants. Further endosymbiosis of green or red 62 
algae by other non-photosynthetic eukaryotes led to the evolution of diverse groups of 63 
algae including euglenoids and diatoms [5]. Illustrating this diversity, diatoms have 64 
retained unique characteristics from different domains of life [6] such as the presence 65 
of the urea cycle [7], which is typical of animals, and a sterol biosynthetic pathway that 66 
uses intermediates from both plant and fungal sterol biosynthesis [8]. The use of 67 
microalgae for lipid stock production has many advantages that have been widely 68 
explored and described [9]: a broad range of microalgal strains can be exploited for oil 69 
production [4, 10]; they can reach high growth rates (1 to 4 divisions per day for the 70 
model green alga, Chlamydomonas reinhardtii [11]); and by consuming CO2 they 71 
contribute to reducing greenhouse gas emissions. Moreover, because microalgae can 72 
use a variety of other inorganic nutrients they can even be exploited for bio-remediation 73 
from wastewaters [3]. Since microalgae are able to grow in controlled environments like 74 
that of photobioreactors as well as under extreme conditions (high salinity, and across 75 
a broad range of temperature and light intensities), they are not subject to seasonal 76 
changes and do not necessarily compete with crops for land and water.  77 
 Microalgae typically produce large amounts of lipids under stress conditions 78 
such as nutrient limitation, and most notably under nitrogen (N) starvation. However, 79 
these stresses interrupt cell proliferation and therefore reduce total biomass and limit 80 
the overall lipid yield. In the last decade there has been a gold rush for the selection of 81 
strains or the creation of engineered microorganisms able to accumulate more lipids. In 82 
this regard a path frequently beaten by researchers is to knockout or overexpress 83 
genes involved in carbon and lipid metabolism [10]. However, the growth of these 84 
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strains is often compromised and a better knowledge of the regulation of the balance 85 
between growth and lipid accumulation is still required. In this context, a new route is 86 
represented by the study of the TOR (Target of Rapamycin) kinase pathway [12], which 87 
is a central hub in the regulation of various cell cycle processes including the regulation 88 
of nutrient and energy homeostasis, lipid synthesis and is conserved in eukaryotes [13]. 89 
We will first present evidence for the importance of TOR signaling in the regulation of 90 
lipid homeostasis from the wealth of studies in animals, and then we will present how 91 
manipulation of TOR signaling can improve TAG productivity in algae. Finally, we will 92 
discuss how recent studies in photosynthetic eukaryotes, in parallel with discoveries on 93 
TOR signaling in animals, can be used to understand how TOR regulates TAG 94 
accumulation in algae and, ultimately, to target TOR signaling for increased lipid 95 
productivity. 96 
 97 
 98 
2. The principal TOR signaling effectors that control lipid metabolism in 99 
animals  100 
 101 
 TOR (Target of Rapamycin) is a large (280 kDa) multi-domain kinase belonging 102 
to the phosphatidylinositol kinase-related kinase (PIKK) family. TOR is inhibited by 103 
rapamycin (Fig. 1) through interaction with the 12 kDa TOR-FRB domain (FKBP12-104 
rapamycin-binding domain). Two canonical TOR containing complexes (TORC), 105 
TORC1 and TORC2, exist in both mammals and yeast. Recently, different forms of a 106 
TORC3 that differ in structure, function and subcellular localization have been 107 
discovered in mammals [14-17]. The TORC1 core, which is composed of the TOR 108 
kinase, RAPTOR (regulatory associated protein of TOR) and LST8 (lethal with SEC13 109 
protein 8), is found in all eukaryotes [18] and is sensitive to the allosteric inhibitor 110 
rapamycin, which binds to the FRB domain of TOR. TORC1 is regulated by nutrients 111 
such as glucose, amino acids, as well as by growth factors and is inhibited by stress-112 
related signals such as starvation and hypoxia. Conserved functions of TORC1 include 113 
the activation of protein, lipid and nucleotide synthesis, as well as promoting 114 
progression of the cell cycle. At the same time, TORC1 also inhibits stress-responsive 115 
genes and catabolic processes like autophagy [19, 20]. Upstream signals are funneled 116 
towards TORC1 via different repressors and activators that regulate TOR intracellular 117 
localization and activity. One of the major upstream repressors of TORC1 is the AMP-118 
activated protein kinase (AMPK), a major sensor of cellular energy status via the 119 
AMP/ATP and ADP/ATP ratio in mammals [21]. The orthologues of AMPK in yeast 120 
(SNF1, sucrose non fermenting 1) and plants (SnRK1, SNF1-related kinase 1) [22, 23] 121 
are not responsive to AMP, indicating that there are distinct strategies for energy 122 
sensing in different organisms. 123 
 As a general rule, active TOR in mammals promotes lipogenesis and 124 
adipogenesis and inhibits lipolysis [24]. Lipid synthesis and storage are promoted by 125 
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the SREBP (sterol regulatory element-binding protein) transcription factor, a master 126 
regulator of the transcription of lipo- and sterolgenic genes such as fatty acid synthase, 127 
acetyl-CoA carboxylase alpha, stearoyl CoA-desaturase, HMG-CoA reductase, and 128 
farnesyl diphosphate synthase [13]. SREBP is retained in the membrane of the 129 
endoplasmic reticulum where it is unable to activate transcription. In response to sterol 130 
depletion SREBP is cleaved and the SREBP DNA-binding domain is imported into the 131 
nucleus where it promotes the transcription of lipogenic enzymes [25]. In mammals, 132 
TORC1 regulates the activation of SREBP via two main mechanisms: the 133 
phosphorylation of (i) the ribosomal S6 kinase 1 (S6K1) to promote lipogenic processes 134 
including the processing of SREBP, and (ii) of lipin-1, a phosphatidic acid phosphatase 135 
(PAH) that converts phosphatidic acid (PA) into DAG, an important precursor of 136 
membrane and neutral lipids. Upon TORC1 inhibition, lipin-1 becomes 137 
dephosphorylated and is imported into the nucleus where it inhibits SREBP to down-138 
regulate lipid synthesis. Interestingly, TORC stability and activity is itself dependent on 139 
PA, which binds the FRB domain of TOR and acts as an indicator of nutrient sufficiency 140 
[26, 27]. Another S6K1 target, the Serine/Arginine (SR)-rich protein kinase 2 (SRPK2), 141 
which controls the expression of lipogenic enzymes was recently reported [28]. It 142 
mediates the phosphorylation of SR proteins and their interaction with the spliceosomal 143 
protein U1-70K, which is responsible for the splicing of lipogenic pre-mRNAs. The 144 
phosphorylation of another mTORC1-S6K target, the glutamylprolyl tRNA synthetase 145 
(EPRS), induces EPRS release from the amino acyl tRNA multisynthetase complex 146 
and its interaction with the fatty acid transport protein 1, promoting its translocation to 147 
the plasma membrane and importing fatty acid to the cells [29]. In addition to inducing 148 
lipogenesis and controlling cellular lipid homeostasis in different cell types in the brain 149 
and liver, mammalian TORC1 also has a positive effect on the differentiation of stem 150 
cells into mature adipocytes and in the formation of adipose tissue [30]. TORC1 151 
controls lipid metabolism in white and brown adipose tissues that respectively favor 152 
lipid storage or lipid use. The mobilization of the energy stored in the form of TAG, 153 
through the action of several lipases [31] and -oxidation of FA can generate either 154 
ATP or heat through the uncoupling protein 1 (UCP1) that decouples the mitochondrial 155 
electrochemical gradient. These processes, which are still under study, illustrate the 156 
fundamental role of TOR in regulating lipid and energy metabolism at the cell and 157 
organism level. 158 
 159 
3.  TOR inhibition can induce a “get fat growth” regime in algae 160 
 161 
 Despite the large diversity and the complex evolution of photosynthetic 162 
eukaryotes, all plants and algae investigated contain a conserved TORC1 with at least 163 
TOR, RAPTOR and LST8 [32]. No other TOR complexes have yet been described in 164 
these groups of organisms. TOR is an essential regulator of proliferation in both plants 165 
and algae as shown by the embryo-lethal phenotype of tor null mutants in plants, and 166 
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the repression of both plant and algal growth by the allosteric TOR inhibitor rapamycin 167 
or by ATP-competitive TOR inhibitors [33-36]. 168 
Two independent studies conducted in plants and algae demonstrated the link 169 
between TOR repression and neutral lipid accumulation [37, 38]. Repression of tor 170 
expression by inducible RNA silencing in Arabidopsis seedlings led to major metabolic 171 
changes including the massive accumulation of storage lipids and starch [37]. 172 
Likewise, repression of TOR activity by rapamycin treatment led to increased levels in 173 
TAG synthesis-related genes, such as glycerol-3-phosphate acyltransferase and acyl-174 
CoA:diacylglycerol acyltransferase (DGAT), and consequently to TAG accumulation in 175 
Cyanidioschyzon merolae (red algae) and Chlamydomonas reinhardtii (green algae) 176 
[39]. These studies were pioneering in that they opened the way to targeting TOR 177 
signaling for improving plant and algal lipid production. More recent studies conducted 178 
on other diverse groups of microalgae, including the diatom Phaeodactylum tricornutum 179 
and the euglenoid Euglena gracilis, showed that TOR inhibition results in the 180 
accumulation of large lipid droplets rather similar to those that appear in response to N 181 
starvation [34, 39-42] (Fig. 2). TOR inhibition also induces lipid droplet accumulation in 182 
budding yeast, suggesting that this phenotype might be a common feature rather than 183 
being specific to photosynthetic eukaryotes [40]. Although TAG accumulation seems to 184 
be a general response to TOR inhibition in algae and plants, other associated 185 
phenotypes are not always similar. For example, while we observed that P. tricornutum 186 
treatment with the ATP-competitive TOR inhibitor AZD-8055 (Fig. 1) could lead to a 187 
stronger decrease in chlorophyll fluorescence than N starvation, no significant effect of 188 
rapamycin on chlorophyll content was observed in C. reinhardtii by Roustan and 189 
Weckwerth [43]. However, while ATP-competitive TOR inhibitors can efficiently inhibit 190 
TOR, rapamycin is less efficient, at least in animals where it only partially inhibits TOR 191 
function [44]. This is probably also the case in algae since rapamycin, even at high 192 
concentrations, only partially represses algal growth to 40-50% of that of untreated 193 
cells [34, 35, 45, 46]. On the other hand, ATP-competitive TOR inhibitors can almost 194 
completely stop algal proliferation [18, 34, 41]. More comparative analyses with similar 195 
TOR inhibitors and at similar effective doses are therefore required to accurately 196 
compare the extent and diversity of TOR functions in different algae. 197 
As discussed above, a major bottleneck in the development of algae for biofuel 198 
production is the fact that most conditions that induce TAG accumulation also repress 199 
growth, which strongly limits productivity. Obviously, this is also a concern with TOR 200 
inhibitors considering the essential and conserved positive function of TOR in the 201 
regulation of cell growth and proliferation. However, analysis of the dose-dependent 202 
effects of AZD-8055 in the diatom P. tricornutum allowed the identification of a dose 203 
that induced a 3 to 4 fold higher lipid productivity than N starvation. This enhanced lipid 204 
productivity was due to a moderated impairment of proliferation that allowed cells to 205 
grow and divide while accumulating TAG, in what was coined a “get fat-growth regime” 206 
[34]. Notably, it is not possible to titrate N to achieve the same effect, because N will be 207 
rapidly consumed by the cells. These results show that fine tuning of TOR activity can 208 
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improve lipid productivity, and underline the need to fully decipher the TOR signaling 209 
axis involved in lipid homeostasis to improve the balance between proliferation and 210 
TAG accumulation. 211 
 212 
 213 
4. How could the TOR signaling pathway regulate neutral lipid accumulation 214 
in algae? 215 
 216 
 Recent phosphoproteomics and pharmacogenetics analyses have identified 217 
potential members of the TOR pathway in photosynthetic eukaryotes. Although some of 218 
these data were obtained in Arabidopsis and have not yet been confirmed in 219 
Chlamydomonas or other more distantly related algae, this section presents an 220 
overview of the potentially conserved TOR signaling axis involved in lipid homeostasis, 221 
and a tentative model of how TOR might regulate TAG accumulation in algae (Fig. 3). 222 
 S6Ks are conserved TOR targets found in plants and algae that are known to 223 
regulate translation [47, 48]. Phosphoproteomic studies of Chlamydomonas cells 224 
treated with rapamycin or AZD-8055 identified TOR-dependent phosphorylation sites in 225 
S6K and ribosomal S6 protein [43, 49]. In mammals, S6K regulates SREBP processing 226 
and other lipogenic genes. However, SREBP homologs are not found in plants and 227 
algae. Interestingly, one of the two Arabidopsis S6Ks localizes to the nucleus, 228 
suggesting its potential involvement in transcriptional regulation [50]. Orthologues of 229 
the SREBP repressor and PAH (lipin-1) are also found in plants and algae [51]. 230 
Arabidopsis has two PAHs (PAH1 and 2), whose loss of function induces increase in 231 
phospholipid content [51]. In algae species, transcriptomics, proteomics or 232 
metabolomics did not report PAHs or PA but this might reflect that such signaling 233 
proteins and PA are hard to detect in the nutrient conditions devoted to increase 234 
cellular lipid contents [52]. In the green microalga Chlorella vulgaris, proteomics studies 235 
reported that S6K increased under nutrient repleted conditions [53] and the 236 
phosphatidic acid phosphatase PAP was identified [54]. Strikingly, PAH2 is 237 
phosphorylated in a TOR dependent manner in Arabidopsis, suggesting a conservation 238 
of the link between TOR and PAH in photosynthetic eukaryotes [55]. PAH1 is also 239 
phosphorylated by the cyclin-dependent kinases (CDKs) in Arabidopsis suggesting a 240 
further link between lipid homeostasis and cell cycle progression [56]. Hence, although 241 
a direct link between S6K/PAH and TAG accumulation has not yet been demonstrated 242 
in algae, their conservation strongly suggests that they may play a significant role in 243 
algal lipid homeostasis (Fig. 3). 244 
Other potential effectors of TOR signaling were directly identified in genetic 245 
screens on algae. First, two members of the DYRK (dual-specificity tyrosine-246 
phosphorylation regulated kinase) family of protein kinases were isolated in screens for 247 
Chlamydomonas insertional mutants defective for oil and starch accumulation [57, 58]. 248 
One, named TAR1 (triacylglycerol accumulation regulator 1) is the homolog of the 249 
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yeast and Arabidopsis YAK1 (yet another kinase 1), and the other, named DYRKP, 250 
belongs to a plant and algal DYRK subfamily. A link between YAK1/DYRK and TOR 251 
signaling was revealed recently in plants during a screen for Arabidopsis mutants 252 
resistant to the TOR inhibitor AZD-8055. Arabidopsis YAK1 is a negative regulator of 253 
growth that is repressed by TOR [59], interacts with TOR, and is phosphorylated in a 254 
TOR-dependent manner [55] but it is not yet clear how TOR-YAK/DYRK signaling 255 
affects TAG levels in algae. Another screen aimed at identifying TOR signaling 256 
effectors in algae led to the identification of the rapamycin-hypersensitive mutant vip1-1 257 
[60]. VIP1 encodes an inositol hexakisphosphate kinase that pyrophosphorylates the 258 
inositol phosphate InsP6 to produce the signaling molecules InsP7 and InsP8. The fact 259 
that InsP7 and InsP8 levels drop in rapamycin-treated wild-type cells confirmed a link 260 
with TOR signaling [60]. Interestingly, the higher levels of TAGs in the vip1-1 mutant led 261 
to the conclusion that InsP7 and InsP8 activate growth at the expense of TAG 262 
accumulation [60]. In Arabidopsis, AZD-8055 leads to increased phosphorylation of the 263 
VIP1 homolog VIP2 suggesting an indirect regulation by TOR [55]. Interestingly, both 264 
tar1 and vip1 mutant phenotypes are dependent on the presence of a carbon source. 265 
tar1 mutant fails to accumulate TAGs when N starvation is coupled to acetate supply 266 
(photomixotrophy) but accumulates high level of TAGs in photoautotrophic N-deficient 267 
conditions [61]. Similarly, vip1 is hypersensitive to TOR inhibitors on acetate supplied 268 
media but not in photoautotrophic conditions [60]. This highlights the importance of the 269 
TOR signaling pathway in integrating different nutrient signals to regulate growth and 270 
reserve accumulation in algae. 271 
 Last but not least, autophagy was the first intracellular process connected to 272 
TOR signaling to be reported in algae. Rapamycin treatment was shown to induce 273 
vacuolization [35] and post-translational modification of the key autophagy-related 274 
protein ATG8 in C. reinhardtii [62]. More recently, ATG7 phosphorylation was shown to 275 
be dependent on TOR [46], suggesting that TOR may regulate autophagy via this 276 
protein. In addition, a recent report showed that treatment of cells with concanamycin 277 
A, an inhibitor of the autophagic flux, repressed TAG accumulation in response to N 278 
starvation. This work indicates that autophagy and vacuolar function are therefore 279 
required for lipid droplet accumulation in Chlamydomonas [63]. It is therefore likely that 280 
the activation of autophagy plays an important role in lipid droplet accumulation in 281 
response to TOR inhibition. 282 
 283 
 284 
Perspectives 285 
  286 
 This minireview shows the importance of measuring proliferation and/or growth 287 
in connection with TAG productivity whatever the context. Manipulation of specific TOR 288 
signaling axis and the use of different ATP competitive inhibitors of TOR, at different 289 
concentrations, may help to achieve a better TAG productivity. Identifying the 290 
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downstream targets of TOR needs further investigations to decipher the top secret of 291 
TOR in different organisms and especially in algae that are still overlooked for TOR 292 
function. More comparative studies are indeed required, particularly between different 293 
algae due to their diversity and because most TOR effectors were studied in the model 294 
green alga Chlamydomonas reinhardtii, which is not necessarily the best choice for 295 
biotechnological applications. It is obvious that there are still many remaining questions 296 
to understand the relationships between TOR and TAG accumulation in algae and 297 
many studies to perform in that fascinating field. 298 
 299 
300 
9 
 
Acknowledgments 301 
 302 
 This work was supported by the ANR SIGNAUX BioNRJ (ANR-15-CE05-0021-303 
03) 304 
 305 
 306 
References  307 
 308 
[1] K.V. Ruggles, A. Turkish, S.L. Sturley, Making, baking, and breaking: the synthesis, storage, and 309 
hydrolysis of neutral lipids, Annual review of nutrition, 33 (2013) 413-451. 310 
[2] Y. Li-Beisson, J.J. Thelen, E. Fedosejevs, J.L. Harwood, The lipid biochemistry of eukaryotic algae, 311 
Progress in lipid research, 74 (2019) 31-68. 312 
[3] S.A. Shields-Menard, M. Amirsadeghi, W.T. French, R. Boopathy, A review on microbial lipids as a 313 
potential biofuel, Bioresource Technology, 259 (2018) 451-460. 314 
[4] Y. Chisti, Biodiesel from microalgae, Biotechnology advances, 25 (2007) 294-306. 315 
[5] T. Cavalier-Smith, Principles of protein and lipid targeting in secondary symbiogenesis: euglenoid, 316 
dinoflagellate, and sporozoan plastid origins and the eukaryote family tree, The Journal of eukaryotic 317 
microbiology, 46 (1999) 347-366. 318 
[6] A.S. Benoiston, F.M. Ibarbalz, L. Bittner, L. Guidi, O. Jahn, S. Dutkiewicz, C. Bowler, The evolution of 319 
diatoms and their biogeochemical functions, Philosophical transactions of the Royal Society of London. 320 
Series B, Biological sciences, 372 (2017). 321 
[7] A.E. Allen, C.L. Dupont, M. Oborník, A. Horák, A. Nunes-Nesi, J.P. McCrow, H. Zheng, D.A. Johnson, H. 322 
Hu, A.R. Fernie, C. Bowler, Evolution and metabolic significance of the urea cycle in photosynthetic 323 
diatoms, Nature, 473 (2011) 203. 324 
[8] M. Fabris, M. Matthijs, S. Carbonelle, T. Moses, J. Pollier, R. Dasseville, G.J.E. Baart, W. Vyverman, A. 325 
Goossens, Tracking the sterol biosynthesis pathway of the diatom Phaeodactylum tricornutum, New 326 
Phytologist, 204 (2014) 521-535. 327 
[9] Q. Hu, M. Sommerfeld, E. Jarvis, M. Ghirardi, M. Posewitz, M. Seibert, A. Darzins, Microalgal 328 
triacylglycerols as feedstocks for biofuel production: perspectives and advances, The Plant journal : for 329 
cell and molecular biology, 54 (2008) 621-639. 330 
[10] M.-H. Liang, J.-G. Jiang, Advancing oleaginous microorganisms to produce lipid via metabolic 331 
engineering technology, Progress in lipid research, 52 (2013) 395-408. 332 
[11] Z.T. Wang, N. Ullrich, S. Joo, S. Waffenschmidt, U. Goodenough, Algal lipid bodies: stress induction, 333 
purification, and biochemical characterization in wild-type and starchless Chlamydomonas reinhardtii, 334 
Eukaryotic cell, 8 (2009) 1856-1868. 335 
[12] R. Loewith, M.N. Hall, Target of rapamycin (TOR) in nutrient signaling and growth control, Genetics, 336 
189 (2011) 1177-1201. 337 
[13] A. Caron, D. Richard, M. Laplante, The Roles of mTOR Complexes in Lipid Metabolism, Annual 338 
review of nutrition, 35 (2015) 321-348. 339 
[14] F.C. Harwood, R.I. Klein Geltink, B.P. O'Hara, M. Cardone, L. Janke, D. Finkelstein, I. Entin, L. Paul, 340 
P.J. Houghton, G.C. Grosveld, ETV7 is an essential component of a rapamycin-insensitive mTOR complex 341 
in cancer, Science advances, 4 (2018) eaar3938. 342 
[15] D. Kazyken, Y. Kaz, V. Kiyan, A.A. Zhylkibayev, C.H. Chen, N.K. Agarwal, D. Sarbassov dos, The 343 
nuclear import of ribosomal proteins is regulated by mTOR, Oncotarget, 5 (2014) 9577-9593. 344 
[16] Y. Luo, L. Liu, Y. Wu, K. Singh, B. Su, N. Zhang, X. Liu, Y. Shen, S. Huang, Rapamycin inhibits mSin1 345 
phosphorylation independently of mTORC1 and mTORC2, Oncotarget, 6 (2015) 4286-4298. 346 
[17] L.J. Smithson, D.H. Gutmann, Proteomic analysis reveals GIT1 as a novel mTOR complex component 347 
critical for mediating astrocyte survival, Genes & development, 30 (2016) 1383-1388. 348 
10 
 
[18] M.H. Montane, B. Menand, TOR inhibitors: from mammalian outcomes to pharmacogenetics in 349 
plants and algae, Journal of experimental botany, (2019). 350 
[19] M. Laplante, D.M. Sabatini, mTOR signaling in growth control and disease, Cell, 149 (2012) 274-351 
293. 352 
[20] R.A. Saxton, D.M. Sabatini, mTOR Signaling in Growth, Metabolism, and Disease, Cell, 168 (2017) 353 
960-976. 354 
[21] P. Crozet, L. Margalha, A. Confraria, A. Rodrigues, C. Martinho, M. Adamo, C.A. Elias, E. Baena-355 
Gonzalez, Mechanisms of regulation of SNF1/AMPK/SnRK1 protein kinases, Frontiers in plant science, 5 356 
(2014) 190. 357 
[22] K.M. Jamsheer, B.N. Shukla, S. Jindal, N. Gopan, C.T. Mannully, A. Laxmi, The FCS-like zinc finger 358 
scaffold of the kinase SnRK1 is formed by the coordinated actions of the FLZ domain and intrinsically 359 
disordered regions, The Journal of biological chemistry, 293 (2018) 13134-13150. 360 
[23] P. Sanz, R. Viana, M.A. Garcia-Gimeno, AMPK in Yeast: The SNF1 (Sucrose Non-fermenting 1) 361 
Protein Kinase Complex, Experientia supplementum (2012), 107 (2016) 353-374. 362 
[24] S.J. Ricoult, B.D. Manning, The multifaceted role of mTORC1 in the control of lipid metabolism, 363 
EMBO reports, 14 (2013) 242-251. 364 
[25] T.I. Jeon, T.F. Osborne, SREBPs: metabolic integrators in physiology and metabolism, Trends in 365 
endocrinology and metabolism: TEM, 23 (2012) 65-72. 366 
[26] D. Menon, D. Salloum, E. Bernfeld, E. Gorodetsky, A. Akselrod, M.A. Frias, J. Sudderth, P.H. Chen, R. 367 
DeBerardinis, D.A. Foster, Lipid sensing by mTOR complexes via de novo synthesis of phosphatidic acid, 368 
The Journal of biological chemistry, 292 (2017) 6303-6311. 369 
[27] M.S. Yoon, Y. Sun, E. Arauz, Y. Jiang, J. Chen, Phosphatidic acid activates mammalian target of 370 
rapamycin complex 1 (mTORC1) kinase by displacing FK506 binding protein 38 (FKBP38) and exerting an 371 
allosteric effect, The Journal of biological chemistry, 286 (2011) 29568-29574. 372 
[28] G. Lee, Y. Zheng, S. Cho, C. Jang, C. England, J.M. Dempsey, Y. Yu, X. Liu, L. He, P.M. Cavaliere, A. 373 
Chavez, E. Zhang, M. Isik, A. Couvillon, N.E. Dephoure, T.K. Blackwell, J.J. Yu, J.D. Rabinowitz, L.C. 374 
Cantley, J. Blenis, Post-transcriptional Regulation of De Novo Lipogenesis by mTORC1-S6K1-SRPK2 375 
Signaling, Cell, 171 (2017) 1545-1558 e1518. 376 
[29] A. Arif, F. Terenzi, A.A. Potdar, J. Jia, J. Sacks, A. China, D. Halawani, K. Vasu, X. Li, J.M. Brown, J. 377 
Chen, S.C. Kozma, G. Thomas, P.L. Fox, EPRS is a critical mTORC1-S6K1 effector that influences adiposity 378 
in mice, Nature, 542 (2017) 357-361. 379 
[30] M.F. Wipperman, D.C. Montrose, A.M. Gotto, Jr., D.P. Hajjar, Mammalian Target of Rapamycin: A 380 
Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health, The American 381 
journal of pathology, 189 (2019) 492-501. 382 
[31] S. D'Andrea, Lipid droplet mobilization: The different ways to loosen the purse strings, Biochimie, 383 
120 (2016) 17-27. 384 
[32] T.J. van Dam, F.J. Zwartkruis, J.L. Bos, B. Snel, Evolution of the TOR pathway, Journal of molecular 385 
evolution, 73 (2011) 209-220. 386 
[33] M.H. Montané, B. Menand, ATP-competitive mTOR kinase inhibitors delay plant growth by 387 
triggering early differentiation of meristematic cells but no developmental patterning change, Journal 388 
of experimental botany, 64 (2013) 4361-4374. 389 
[34] L. Prioretti, L. Avilan, F. Carriere, M.-H. Montane, B. Field, G. GREGORI, B. Menand, B. Gontero, The 390 
inhibition of TOR in the model diatom Phaeodactylum tricornutum promotes a get-fat growth regime, 391 
Algal Research - Biomass, Biofuels and Bioproducts, 26 (2017) 265-274. 392 
[35] J.L. Crespo, S. Diaz-Troya, F.J. Florencio, Inhibition of target of rapamycin signaling by rapamycin in 393 
the unicellular green alga Chlamydomonas reinhardtii, Plant Physiol, 139 (2005) 1736-1749. 394 
[36] B. Menand, T. Desnos, L. Nussaume, F. Berger, D. Bouchez, C. Meyer, C. Robaglia, Expression and 395 
disruption of the Arabidopsis TOR (target of rapamycin) gene, Proceedings of the National Academy of 396 
Sciences of the United States of America, 99 (2002) 6422-6427. 397 
11 
 
[37] C. Caldana, Y. Li, A. Leisse, Y. Zhang, L. Bartholomaeus, A.R. Fernie, L. Willmitzer, P. Giavalisco, 398 
Systemic analysis of inducible target of rapamycin mutants reveal a general metabolic switch controlling 399 
growth in Arabidopsis thaliana, The Plant journal : for cell and molecular biology, 73 (2013) 897-909. 400 
[38] D.Y. Lee, O. Fiehn, Metabolomic response of Chlamydomonas reinhardtii to the inhibition of target 401 
of rapamycin (TOR) by rapamycin, Journal of microbiology and biotechnology, 23 (2013) 923-931. 402 
[39] S. Imamura, Y. Kawase, I. Kobayashi, T. Sone, A. Era, S.Y. Miyagishima, M. Shimojima, H. Ohta, K. 403 
Tanaka, Target of rapamycin (TOR) plays a critical role in triacylglycerol accumulation in microalgae, 404 
Plant molecular biology, 89 (2015) 309-318. 405 
[40] J.B. Madeira, C.A. Masuda, C.M. Maya-Monteiro, G.S. Matos, M. Montero-Lomeli, B.L. Bozaquel-406 
Morais, TORC1 inhibition induces lipid droplet replenishment in yeast, Molecular and cellular biology, 407 
35 (2015) 737-746. 408 
[41] S. Imamura, Y. Kawase, I. Kobayashi, M. Shimojima, H. Ohta, K. Tanaka, TOR (target of rapamycin) is 409 
a key regulator of triacylglycerol accumulation in microalgae, Plant signaling & behavior, 11 (2016) 410 
e1149285. 411 
[42] S. Mukaida, T. Ogawa, K. Ohishi, Y. Tanizawa, D. Ohta, M. Arita, The effect of rapamycin on 412 
biodiesel-producing protist Euglena gracilis, Bioscience, biotechnology, and biochemistry, 80 (2016) 413 
1223-1229. 414 
[43] V. Roustan, W. Weckwerth, Quantitative Phosphoproteomic and System-Level Analysis of TOR 415 
Inhibition Unravel Distinct Organellar Acclimation in Chlamydomonas reinhardtii, Frontiers in plant 416 
science, 9 (2018) 1590. 417 
[44] S.A. Kang, M.E. Pacold, C.L. Cervantes, D. Lim, H.J. Lou, K. Ottina, N.S. Gray, B.E. Turk, M.B. Yaffe, 418 
D.M. Sabatini, mTORC1 phosphorylation sites encode their sensitivity to starvation and rapamycin, 419 
Science (New York, N.Y.), 341 (2013) 1236566. 420 
[45] J. Juppner, U. Mubeen, A. Leisse, C. Caldana, A. Wiszniewski, D. Steinhauser, P. Giavalisco, The 421 
target of rapamycin kinase affects biomass accumulation and cell cycle progression by altering 422 
carbon/nitrogen balance in synchronized Chlamydomonas reinhardtii cells, The Plant journal : for cell 423 
and molecular biology, 93 (2018) 355-376. 424 
[46] V. Roustan, S. Bakhtiari, P.-J. Roustan, W. Weckwerth, Quantitative in vivo phosphoproteomics 425 
reveals reversible signaling processes during nitrogen starvation and recovery in the biofuel model 426 
organism Chlamydomonas reinhardtii, Biotechnology for Biofuels, 10 (2017) 280. 427 
[47] T. Dobrenel, E. Mancera-Martínez, C. Forzani, M. Azzopardi, M. Davanture, M. Moreau, M. 428 
Schepetilnikov, J. Chicher, O. Langella, M. Zivy, C. Robaglia, L.A. Ryabova, J. Hanson, C. Meyer, The 429 
Arabidopsis TOR Kinase Specifically Regulates the Expression of Nuclear Genes Coding for Plastidic 430 
Ribosomal Proteins and the Phosphorylation of the Cytosolic Ribosomal Protein S6, Frontiers in plant 431 
science, 7 (2016) 1611. 432 
[48] J. Serfontein, R.E. Nisbet, C.J. Howe, P.J. de Vries, Evolution of the TSC1/TSC2-TOR signaling 433 
pathway, Science signaling, 3 (2010) ra49. 434 
[49] E.G. Werth, E.W. McConnell, I. Couso Lianez, Z. Perrine, J.L. Crespo, J.G. Umen, L.M. Hicks, 435 
Investigating the effect of target of rapamycin kinase inhibition on the Chlamydomonas reinhardtii 436 
phosphoproteome: from known homologs to new targets, New Phytologist, 221 (2019) 247-260. 437 
[50] M.M. Mahfouz, S. Kim, A.J. Delauney, D.P. Verma, Arabidopsis TARGET OF RAPAMYCIN interacts 438 
with RAPTOR, which regulates the activity of S6 kinase in response to osmotic stress signals, The Plant 439 
cell, 18 (2006) 477-490. 440 
[51] Y. Nakamura, R. Koizumi, G. Shui, M. Shimojima, M.R. Wenk, T. Ito, H. Ohta, Arabidopsis lipins 441 
mediate eukaryotic pathway of lipid metabolism and cope critically with phosphate starvation, 442 
Proceedings of the National Academy of Sciences of the United States of America, 106 (2009) 20978-443 
20983. 444 
[52] N. Arora, P.T. Pienkos, V. Pruthi, K.M. Poluri, M.T. Guarnieri, Leveraging algal omics to reveal 445 
potential targets for augmenting TAG accumulation, Biotechnology advances, 36 (2018) 1274-1292. 446 
12 
 
[53] M.T. Guarnieri, A. Nag, S. Yang, P.T. Pienkos, Proteomic analysis of Chlorella vulgaris: potential 447 
targets for enhanced lipid accumulation, Journal of proteomics, 93 (2013) 245-253. 448 
[54] M.T. Guarnieri, A. Nag, S.L. Smolinski, A. Darzins, M. Seibert, P.T. Pienkos, Examination of 449 
triacylglycerol biosynthetic pathways via de novo transcriptomic and proteomic analyses in an 450 
unsequenced microalga, PloS one, 6 (2011) e25851. 451 
[55] J. Van Leene, C. Han, A. Gadeyne, D. Eeckhout, C. Matthijs, B. Cannoot, N. De Winne, G. Persiau, E. 452 
Van De Slijke, B. Van de Cotte, E. Stes, M. Van Bel, V. Storme, F. Impens, K. Gevaert, K. Vandepoele, I. 453 
De Smet, G. De Jaeger, Capturing the phosphorylation and protein interaction landscape of the plant 454 
TOR kinase, Nature plants, 5 (2019) 316-327. 455 
[56] C.P. Craddock, N. Adams, J.T. Kroon, F.M. Bryant, P.J. Hussey, S. Kurup, P.J. Eastmond, Cyclin-456 
dependent kinase activity enhances phosphatidylcholine biosynthesis in Arabidopsis by repressing 457 
phosphatidic acid phosphohydrolase activity, The Plant journal : for cell and molecular biology, 89 458 
(2017) 3-14. 459 
[57] M. Kajikawa, Y. Sawaragi, H. Shinkawa, T. Yamano, A. Ando, M. Kato, M. Hirono, N. Sato, H. 460 
Fukuzawa, Algal dual-specificity tyrosine phosphorylation-regulated kinase, triacylglycerol accumulation 461 
regulator1, regulates accumulation of triacylglycerol in nitrogen or sulfur deficiency, Plant Physiol, 168 462 
(2015) 752-764. 463 
[58] M. Schulz-Raffelt, V. Chochois, P. Auroy, S. Cuine, E. Billon, D. Dauvillee, Y. Li-Beisson, G. Peltier, 464 
Hyper-accumulation of starch and oil in a Chlamydomonas mutant affected in a plant-specific DYRK 465 
kinase, Biotechnol Biofuels, 9 (2016) 55. 466 
[59] A. Barrada, M. Djendli, T. Desnos, R. Mercier, C. Robaglia, M.H. Montane, B. Menand, A TOR-YAK1 467 
signaling axis controls cell cycle, meristem activity and plant growth in Arabidopsis, Development, 146 468 
(2019). 469 
[60] I. Couso, B.S. Evans, J. Li, Y. Liu, F. Ma, S. Diamond, D.K. Allen, J.G. Umen, Synergism between 470 
Inositol Polyphosphates and TOR Kinase Signaling in Nutrient Sensing, Growth Control, and Lipid 471 
Metabolism in Chlamydomonas, The Plant cell, 28 (2016) 2026-2042. 472 
[61] H. Shinkawa, M. Kajikawa, Y. Nomura, M. Ogura, Y. Sawaragi, T. Yamano, H. Nakagami, N. 473 
Sugiyama, Y. Ishihama, Y. Kanesaki, H. Yoshikawa, H. Fukuzawa, Algal Protein Kinase, Triacylglycerol 474 
Accumulation Regulator1, Modulates Cell Viability and Gametogenesis in Carbon/Nitrogen Imbalanced 475 
Conditions, Plant & cell physiology, (2019). 476 
[62] M.E. Perez-Perez, I. Couso, J.L. Crespo, The TOR Signaling Network in the Model Unicellular Green 477 
Alga Chlamydomonas reinhardtii, Biomolecules, 7 (2017). 478 
[63] I. Couso, M.E. Perez-Perez, E. Martinez-Force, H.S. Kim, Y. He, J.G. Umen, J.L. Crespo, Autophagic 479 
flux is required for the synthesis of triacylglycerols and ribosomal protein turnover in Chlamydomonas, 480 
Journal of experimental botany, 69 (2018) 1355-1367. 481 
 482 
 483 
Figure legends 484 
 485 
Fig. 1. Chemical structures of the TOR inhibitors rapamycin (A) and AZD-8055 (B).  486 
 487 
Fig. 2. Effect of TOR inhibition on lipid storage in microalgae. A) Nile Red staining of 488 
lipid droplets in Phaeodactylum tricornutum after five days of treatment with DMSO 489 
(left) or AZD-8055 2 µM (right), scale bars 10 µm (modified with permission from 490 
Prioretti et al. 2017). B) BODIPY and AC-202 merged staining of lipid droplets in 491 
Chlamydomonas reinhardtii after 48h of treatment with DMSO (left) or AZD-8055 2 µM 492 
(right), scale bar 5 µm (modified from Harchouni et al. 2018). C) BODIPY staining of 493 
lipid droplets in a rapamycin-sensitive strain of Cyanidioschyzon merolae expressing 494 
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yeast FKBP12 after 48h of treatment with DMSO (left) or rapamycin 1 µM (right), scale 495 
bars 10 µm (modified with permission from Imamura et al. 2015). D) Nile Red staining 496 
of lipid droplets in Euglena gracilis after five days of treatment with ethanol (left) or 497 
rapamycin 1 µM (right), scale bars 20 µm (modified with permission from Mukaida et al. 498 
2016).  499 
 500 
Fig. 3. Model of effectors of TOR-dependent regulation of growth and lipid homeostasis 501 
in microalgae. 502 
 503 
 504 
 505 
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